This is a news story, published by VOA, that relates primarily to Sierra Leone news.
For more vaccine development news, you can click here:
more vaccine development newsFor more news from VOA, you can click here:
more news from VOAOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
Ebola outbreak. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest first nationwide preventive vaccination campaign news, nationwide vaccine campaign news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
dose Ebola vaccineVOA
•
76% Informative
The 2014 Ebola outbreak killed nearly 4,000 out of 11,000 recorded globally.
Sierra Leone lost 7% of its health care workforce to the deadly outbreak.
The single-dose Ebola vaccine will target 20,000 front-line workers across the country, officials say.
There had been no approved vaccine at the time of the 2014 outbreak.
VR Score
87
Informative language
91
Neutral language
81
Article tone
semi-formal
Language
English
Language complexity
50
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links